

經營團隊
-
Antony Hsu
PresidentAntony Hsu is responsible for Caliway’s business development activities, including fundraising, commercialization and corporate development, and launch planning.
-
Vivian Ling
Chief Executive Officer/Chief R&D OfficerVivian Ling is responsible for Caliway’s Research & Development, including drug discovery research, non-clinical and clinical development, and regulatory affairs.
-
April Yuan
VPApril Yuan is responsible for Caliway's corporate development affairs, including out-licensing negotiation, public relations, and medical affairs.
-
Dr. Kao-Jung Chang
DirectorDr. Chang is mainly responsible for the clinical application of new drugs.